Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine and metabolic disorder, in which the interaction between insulin resistance (IR) and hyperandrogenism (HA) is a major driver of reproductive and metabolic complications. Accumulating evidence suggests that chromatin remodeling may represent a regulatory layer linking metabolic stress, inflammation, steroidogenic gene expression, and androgen receptor activity. Research indicates that chromatin remodeling may be a key regulatory factor linking metabolic stress, inflammation, steroidogenic gene expression, and androgen receptor activity. This review systematically summarizes current evidence on chromatin remodeling in PCOS-related IR and HA, focusing on histone modifications, DNA methylation, ATP-dependent remodeling complexes, transcription factors, and non-coding RNA-mediated regulation. We distinguish between direct evidence from PCOS tissues and cells and indirect evidence from metabolic, endocrine, and hormone-responsive disease models, proposing a hierarchy of evidence. Available data suggest that chromatin remodeling may influence insulin signaling genes, adipogenesis, ovarian steroidogenic enzymes, and co-transcriptional networks involving Forkhead box protein O1 (FOXO1), Peroxisome Proliferator-Activated Receptor γ (PPARγ), nuclear factor-kappa B (NF-κB), androgen receptor (AR) signaling, and SWI/SNF-related complexes. However, PCOS-specific functional validation remains limited, particularly in theca cells, granulosa cells, adipose tissue, and cell-type-resolved chromatin. Integrating multi-omics, single-cell epigenomics, and CRISPR-based epigenome editing may help identify causal chromatin regulators and clinically relevant PCOS subtypes. We further discuss how computational biomedical approaches, including bioinformatics, Artificial Intelligence (AI), machine learning, and multi-omics integration, can enhance mechanistic inference, biomarker discovery, and PCOS subtype stratification. A chromatin-centric framework may deepen our understanding of the IR-HA cycle and support future biomarker discovery and precision interventions in PCOS.

Aims: Cervical cancer is the second most common cancer globally in women of reproductive age. Current immunotherapies offer only moderate improvement in overall survival for metastatic or refractory disease, highlighting the need for more effective, patient-directed immunotherapies.

Methods: A unified pipelinereprocessed all The Cancer Genome Atlas (TCGA) and genotype tissue expression (GTEx) samples from raw reads using identical alignment and quantification parameters to screen a curated set of 259 high-confidence surface protein genes. This analysis provided the foundation for selecting differentially overexpressed cell surface receptors as potential antibody-drug conjugate (ADCs) targets . Recombinant single chain variable fragment (scFv)-O6-alkylguanine-DNA alkyltransferase (SNAP) fusion proteins were expressed, purified and characterised using immunoblotting. The dose-dependent and selective cytotoxicity of an auristatin F-conjugated (scFv)-SNAP fusion protein was verified in vitro.

Results: Bioinformatic screening revealed 30 potential targets overexpressed in cervical carcinoma (Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC)) vs. healthy tissues. Tissue-of-origin analysis (endocervix vs. ectocervix) further refined priorities. These results, together with supporting evidence from the literature, justified drug production.. The (scFv)-SNAP fusion proteins exhibited strong surface binding across cervical cancer cell lines and, when conjugated to auristatin F, showed dose-dependent cytotoxicity at nanomolar concentrations, confirming the differences observed in transcriptomic analyses of endo- vs. ectocervix profiling.

Conclusion: Bioinformatics and in vitro validation synergize powerfully from initial screening through subtype refinement to iterative target confirmation, enabling a precision medicine approach for cervical cancer-specific immunotherapies. The (scFv)-SNAP-auristatin F (ADC) conjugates reproduced this refinement, showing highly promising potential.

Antibody polyreactivity refers to the ability of a monoclonal antibody to non-specifically bind to a diverse range of antigens. While this property may be an intrinsic mechanism of the immune response, it poses significant challenges in therapeutic antibody development, often leading to off-target effects, poor pharmacokinetics, and potential toxicity. This review compiles the data resources related to polyreactive antibodies and places a particular emphasis on computational models for predicting antibody polyreactivity. The latter includes empirical models based on physicochemical properties, traditional machine learning models, deep learning networks, and protein language models. Through delineating the complexity of antibody polyreactivity, this review emphasizes the critical role and growing potential of computational prediction tools in selecting and engineering antibody drug candidates at early stages, thereby reducing development risks and accelerating the development of safer and better therapeutic antibodies.

Aims: Circular RNAs (circRNAs) have been shown to be closely associated with the occurrence and progression of various diseases. However, most existing circRNA-disease association prediction methods are limited to homogeneous networks and are unable to effectively capture deep semantic associations through high-order meta-paths. This study aims to develop an efficient computational method for accurately predicting potential circRNA-disease associations.

Methods: We propose a meta-relation-aware heterogeneous graph learning framework for circRNA-disease association prediction. Specifically, known circRNA-disease associations are first used to compute Gaussian interaction profile kernel similarity and extract node attribute features, based on which a heterogeneous graph network is constructed. A graph neural network is then employed to perform multi-layer message passing on the heterogeneous graph, aggregating neighborhood information to achieve deep fusion of multi-source features and generate node embeddings that encode both local and global structural information. Finally, the learned embeddings are fed into a gradient boosting decision tree classifier, and an ensemble strategy is adopted to improve prediction accuracy. Five-fold cross-validation is used for performance evaluation.

Results: Experimental results on three benchmark datasets, CircR2Disease V2.0, circAtlas 3.0, and circRNADisease V2.0, show that the proposed model achieves area under the receiver operating characteristic curve (AUC) values of 92.17%, 91.83%, and 91.73%, respectively. The model outperforms traditional methods in terms of accuracy, precision, and recall. Furthermore, ablation studies validate the effectiveness of the meta-relation-aware strategy.

Conclusions: Overall, this work provides an efficient and reliable computational framework for molecular association prediction and biomarker discovery in the biomedical domain.

Aims: Alternative splicing serves as a primary mechanism for diversifying the proteome, making the prediction of distinct isoform functions critical for understanding complex disease mechanisms. However, determining the specific functional roles of isoforms remains hindered by high sequence homology among variants and the sparsity of isoform-level annotations.

Methods: In this study, we propose SpliceEM, a deep learning framework for isoform function prediction at single-cell resolution. SpliceEM utilizes a splicing event-aware encoder with cross-modal attention to separate functional signals from global protein sequences. A Heterogeneous Graph Transformer captures the dependencies among isoforms, genes, and Gene Ontology terms. To bridge the annotation gap, we incorporate a self-distillation framework guided by an Exponential Moving Average teacher model and Multi-Instance Learning, optimized by an Asymmetric Loss and hierarchical constraints.

Results: Benchmarking on human datasets demonstrates that SpliceEM outperforms existing methods in isoform function prediction, particularly in identifying rare functional terms under data-sparse conditions. Furthermore, splicing-function analysis reveals that specific splicing events, such as skipped exons and alternative first exons, act as prominent drivers in oncogenic signaling cascades and context-specific functional switching.

Conclusion: SpliceEM provides a computational foundation for exploring transcriptomic functional diversity. By shifting the focus from global sequences to localized splicing events and utilizing hierarchical biological priors, it offers high-resolution insights into cell-type-specific molecular mechanisms and potential therapeutic targets.

Aims: Single-cell RNA sequencing (scRNA-seq) has emerged as a cornerstone technology in tumor microenvironment research. Accurate cell-type annotation is fundamental to downstream scRNA-seq analysis. However, automated tools are often highly sensitive to dataset noise and show limited adaptability in cross-patient scenarios. To address these challenges, we propose scAdaptAnno, a graph-based target domain adaptation framework for cross-patient single-cell annotation.

Methods: In the graph construction phase, scAdaptAnno integrates both gene expression similarity and biological prior knowledge to build a more biologically meaningful cell graph. By leveraging cell representations enriched with biological priors to mitigate noise in gene expression data and by implementing a bidirectional adaptation mechanism, the model achieves source-free target domain alignment.

Results: We performed comprehensive benchmarking against nine leading methods across multiple datasets spanning various cancer types. The results demonstrate that scAdaptAnno achieves state-of-the-art performance.

Conclusion: scAdaptAnno is a robust and accurate single-cell annotation tool that excels in cross-patient cell-type annotation transfer. By integrating biologically informed graph construction and bidirectional source-free domain adaptation, it delivers reliable, noise-resistant performance across diverse tumor microenvironments, providing an effective solution for automated cell-type annotation in multi-patient scRNA-seq studies.

Aims: Single-cell RNA-sequencing (RNA-seq) enables high-resolution gene regulatory network (GRN) analysis in specific cell types, but data sparsity, noise, and complex regulatory relationships remain major challenges. Existing methods often focus on pairwise gene associations and insufficiently capture global network topology. This study aims to develop a deep graph framework for single-cell GRN inference by integrating global regulatory structure with biologically informed distributional regularization.

Methods: We propose ZINB-GRAN, a graph adversarial framework for single-cell GRN inference. It constructs a weighted gene co-expression matrix as a prior regulatory graph and reformulates GRN inference as a link prediction task. A graph convolutional encoder learns latent gene representations, while a decoder reconstructs network topology. To enhance biological consistency, a multilayer perceptron-based discriminator aligns encoder-derived representations with a continuous zero-inflated negative binomial (ZINB)-derived prior generated through ZINB sampling, logarithmic transformation, normalization, and Gaussian perturbation.

Results: ZINB-GRAN jointly optimizes network reconstruction and latent distribution alignment using mask-based supervised classification and adversarial losses. This strategy improves regulatory structure discrimination and robustness in sparse single-cell data. Benchmarking on simulated and real datasets shows that ZINB-GRAN outperforms most existing GRN inference methods and identifies cell type-specific GRNs and key regulatory factors in human peripheral blood mononuclear cells (PBMCs) and triple-negative breast cancer.

Conclusion: ZINB-GRAN integrates global network topology, graph convolutional representation learning, and continuous ZINB-derived prior regularization for single-cell GRN inference. By aligning latent representations with a biologically motivated prior, it improves the robustness and interpretability of GRN reconstruction and provides a useful tool for cell-specific network inference, key regulator identification, and biomarker discovery.

In recent years, attention mechanisms have gained widespread application and significant advancements in the field of biological sequence analysis. This paper systematically summarizes the fundamental principles of attention mechanisms and their latest research progress in biological sequence analysis. First, the development history of attention mechanisms is introduced, with a focus on classic mechanisms such as self-attention, cross-attention, and multi-head attention, along with their improved variants. Next, a brief overview of the classification and characteristics of bioinformatics databases is provided. Subsequently, the application of attention mechanisms in the analysis of DNA, RNA, and protein sequences is highlighted. In the realm of DNA sequence analysis, attention mechanisms have been applied to tasks such as epigenetic analysis and regulatory element identification; in RNA sequence analysis, they play a crucial role in single-cell RNA sequencing, RNA function prediction, and structure prediction; in protein sequence analysis, attention mechanisms are widely used in protein classification, function prediction, structure prediction, site prediction, and interaction prediction. Furthermore, this paper summarizes the applications of attention mechanisms in other biological sequence analysis tasks, such as multi-omics analysis and enzyme analysis. The attention mechanisms can significantly improve the accuracy, interpretability, and computational efficiency of biological sequence analysis, providing powerful computational tools for bioinformatics research.

Aims: The Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein family of Mycobacterium tuberculosis plays a critical role in virulence, immune evasion, and host-pathogen interactions. However, the high guanine-cytosine-content and repetitive sequences of these proteins have long hindered accurate gene identification and functional annotation. This study aims to develop an effective computational framework to improve the identification of PE/PPE proteins.

Methods: We propose PIONEER, a structure-aware deep learning framework that integrates embeddings from the pre-trained protein language model ESM Cambrian (ESMC) with structural features. PIONEER represents proteins as residue-level graphs that encode both sequence semantics and three-dimensional topological structure, enabling effective modelling of hierarchical geometric relationships.

Results: Benchmarking demonstrates that PIONEER outperforms 16 traditional machine learning algorithms and the existing deep learning model across multiple evaluation metrics, including accuracy, Matthew’s correlation coefficient, and F1 scores. Ablation experiments confirm the complementary contributions of ESMC embeddings and secondary structure features to model performance. The t-SNE-based visualization results reveal the contributions of features across different network layers to the identification of PE/PPE proteins.

Conclusion: PIONEER improves the accuracy of PE/PPE protein identification by integrating sequence and structural information within a structure-aware graph learning framework. This method provides an effective computational tool for functional annotation, investigation of pathogenicity mechanisms, and vaccine target discovery in M. tb.

Aims: To develop a robust and clinically feasible framework for cancer survival prediction using only histopathology images while leveraging transcriptomic knowledge during training.

Aims: To develop a robust and clinically feasible framework for cancer survival prediction using only histopathology images while leveraging transcriptomic knowledge during training.

Methods: The study proposed Adaptive Multi-modality Knowledge Distillation (AMKD), a framework designed to transfer complementary molecular-level information from transcriptomic data to pathology-based models. The AMKD framework consists of two essential elements. First, a gene-guided pathology enhancement module is designed to inject genomics-aware information from a multimodal teacher into pathology features. Second, an adaptive redundancy reduction loss is introduced to regulate knowledge distillation by accounting for prediction discrepancies between teacher and student models. This design allows the student model to retain biologically meaningful knowledge during training and remain effective with only histopathology data at inference.

Results: Comprehensive experiments on four The Cancer Genome Atlas (TCGA) cancer cohorts demonstrate that AMKD achieves state-of-the-art survival prediction performance, with an average concordance index (C-index) of 0.669, surpassing both unimodal pathology-based and fully multi-modal approaches. External validation on the independent Clinical Proteomic Tumor Analysis Consortium head and neck squamous cell carcinoma (CPTAC-HNSC) cohort further confirms the robustness and cross-dataset generalization ability of the proposed framework. Ablation studies further confirm the effectiveness of each proposed component in enhancing cross-modal knowledge transfer and improving generalization under incomplete modality scenarios.

Conclusion: The proposed AMKD framework provides a clinically practical solution for robust cancer survival analysis when transcriptomic data are unavailable. By adaptively distilling multi-modal knowledge into a pathology-based model, AMKD bridges the gap between research and clinical applicability, enabling scalable and cost-effective prognostic prediction in real-world settings.

Aims: Since distal enhancers are involved in regulating target genes through physical contacting with proximal promoters, identifying enhancer-promoter interactions (EPIs) is critical to deepening our understanding of gene expression. However, high-throughput experimental methods for identifying EPIs are time-consuming and expensive. Therefore, computational methods for predicting EPIs would be valuable and important, but also face a lot of challenges.

Methods: In this paper, we propose a novel deep learning-based method, namely EPIPAM, to predict EPIs only using genomic sequences. EPIPAM firstly uses a deep convolutional neural network to extract high-level sequence features, and then uses a position attention mechanism to compute the positional correlation coefficients of two subregions separately coming from enhancers and promoters, aiming to focus on important regions of them.

Results: Benchmarking comparisons on six different cell lines show that EPIPAM performs better than the state-of-the-art methods in the task of EPIs prediction. More importantly, we notice that, almost without exception, the predictive performance of all methods is really poor once applying a strategy of splitting training and test data by chromosome. Therefore, we explain the possible reason that leads to this situation by systematically exploring the structure of EPI datasets, and indirectly analyze the difficulty of predicting EPIs only using genomic sequences through ChIA-PET contact datasets.

Conclusion: This study presents a novel deep learning-based method to predict EPIs only using genomic sequences. Although the proposed method achieves higher predictive accuracy, it suffers from several limitations, such as highly selective matching bias, negative sample selection issues, and constraints of pre-trained vectors.

Aims: EffecTri aims to develop a comprehensive, multi-class prediction framework to accurately identify bacterial effector proteins secreted by Type III, IV, and VI secretion systems. Current methodologies often employ binary classifications, overlooking the complexity and interactions among multiple effector classes.

Methods: EffecTri integrates deep contextual embeddings from Evolutionary Scale Modeling and handcrafted descriptors, including Amino Acid Composition and Dipeptide Composition. The performance of the model was rigorously evaluated through comparative descriptor analyses and optimized feature combinations, complemented by Uniform Manifold Approximation and Projection visualization for interpretability.

Results: EffecTri outperformed traditional machine learning methods, achieving a weighted F1-score of 0.850 on an independent test dataset. The fusion of Evolutionary Scale Modeling embeddings with handcrafted descriptors demonstrated superior predictive performance, clearly distinguishing effector classes in UMAP visualizations.

Conclusion: EffecTri represents a robust, interpretable, and accurate computational tool, enhancing the multi-class identification of bacterial secretory effectors and contributing valuable insights into bacterial pathogenic mechanisms.

Aims: Medical image translation is widely used for data augmentation and cross-domain adaptation in clinical image analysis. However, the nature of medical imaging makes it challenging to collect high-quality samples for the training of translation models. Because of the limited access to and costly expense of medical images, distribution bias is commonly observed between the source and target samples, and this finally leads the models to mismatch the target domain.

Methods: To promote medical image translation, a bias correction method, named content adaptation, has been proposed in this study to align the training samples in the data space. Based on the invariant medical topological structure, paired samples are constructed from weakly paired and unpaired data using content adaptation to correct the distribution bias and promote the image-to-image translation.

Results: Experiments on retinal fundus image translation and COVID-19 CT synthesis demonstrate that the proposed method effectively suppresses structural hallucination and improves both visual quality and quantitative performance. Consistent gains are observed across multiple backbone models under different supervision settings. The results suggest that explicit anatomical alignment provides an effective and model-agnostic way to mitigate distribution bias in medical image translation. By bridging weakly paired data with paired translation paradigms, the proposed approach enhances structural fidelity without requiring strong supervision.

Conclusion: This work presents a topology-guided content adaptation strategy that improves robustness and reduces hallucination in medical image translation. The proposed framework is general and can be readily integrated into existing translation models, offering a practical solution for data-scarce medical imaging scenarios.

Aims: Neural networks capable of capturing temporal dependencies in electroencephalogram (EEG) signals hold considerable potential for seizure prediction by modeling the progressive evolution of preictal EEG changes. However, redundant or less informative temporal features may obscure critical preictal patterns, limiting seizure prediction performance. To address this, we developed a neural architecture that effectively leverages informative temporal features to enhance seizure prediction capability.

Methods: We designed a bidirectional long short-term memory (BiLSTM) network enhanced with a channel attention mechanism, termed Attention-BiLSTM, which adaptively emphasizes informative temporal features while reducing information redundancy. We further analyze the model’s attention weights and feature distributions to provide interpretable insights into its decision-making process.

Results: Evaluation on the CHB-MIT scalp EEG dataset demonstrates that Attention-BiLSTM achieves significant performance improvements over the baseline BiLSTM, with an average accuracy of 94.77%, sensitivity of 94.58%, specificity of 94.97%, and an area under the curve of 98.38%. Furthermore, visualization results indicate that the proposed model progressively enhances feature discriminability and directs attention to the most relevant temporal features for seizure prediction.

Conclusion: The proposed Attention-BiLSTM achieves improved performance and interpretability, offering valuable insights to support future development of scalable and generalizable seizure prediction systems.

Aims: Accurately identifying diagnostic biomarkers for Autism Spectrum Disorder (ASD) is crucial for enabling early diagnosis and timely intervention. Brain causal networks, which outline causal relationships and information transmission pathways among different brain regions, hold significant diagnostic value for ASD. Identifying ASD-relevant causal relationships between brain regions is critical for ASD diagnosis and for elucidating its pathophysiology. This study proposes a new model called the Peter and Clark Momentary Conditional Independence (PCMCI)-Support Vector Machine (SVM) model, which can identify diagnostic biomarkers for ASD.

Methods: The brain blood oxygen level-dependent signals of 116 brain regions from 167 participants, consisting of 72 participants with ASD and 95 Typical Controls (TCs), were used to derive brain causal networks by detecting inter-regional causal relationships using five causal discovery algorithms; the PCMCI algorithm, spectral dynamic causal modeling, Granger causal analysis, Transfer Entropy, and Liang-Kleeman information flow causal analysis. Then, the brain causal relationships were fed into the SVM, Random Forest (RF), and K-Nearest Neighbors (KNN) classifiers, respectively to classify individuals with ASD and TCs, and thereby obtain a model suitable for identifying diagnostic biomarkers for ASD through causal network analysis.

Results: Experimental results demonstrate that the PCMCI-SVM model achieves an accuracy of 91.29% in ASD identification and outperforms the other four causal discovery algorithms, as well as the RF and KNN classifiers. Moreover, our analysis indicates that the right thalamus and right middle temporal gyrus are potential diagnostic biomarkers for ASD. Additionally, the causal relationship between [left inferior parietal→right insula] was found to be associated with the dorsal attention network, while [right cuneus→left cuneus] was associated with the visual network, suggesting that disruptions in these causal relationships may impair the functional integrity of their respective subnetworks.

Conclusion: Our findings show that cognitive processes and brain connectivity are largely influenced by causal interactions between different brain regions. These potential diagnostic biomarkers not only offer insights into the neurofunctional mechanisms of ASD but also hold promise for improving diagnostic accuracy for ASD.

Aims: Driver mutations are crucial factors in the occurrence and development of cancer. Identifying cancer-related driver genes is of great significance for understanding the mechanisms of cancer initiation, prevention, and treatment. With the continuous accumulation of cancer data, how to effectively utilize these data for the identification of cancer driver genes has become a major challenge in the field of cancer biology.

Methods: We propose a novel computational model called iCDG-MOHGAT. This model integrates multi-omics pan-cancer data (such as mutations, DNA methylation, etc.), multi-dimensional gene networks, and disease semantic similarity networks to identify cancer driver genes. We first construct multi-dimensional gene networks using various types of gene correlation information (protein-protein interaction, gene sequence similarity, etc.) and establish disease semantic similarity networks for relevant cancers. Due to the complexity of node and edge types, we utilize a heterogeneous graph attention network to learn and extract features from the multi-dimensional gene networks and disease semantic similarity networks. We also incorporate a fusion learning module to effectively integrate features from different dimensions. Finally, we optimize the random forest classifier using the sparrow algorithm for the task of predicting cancer driver genes.

Results: Experimental results demonstrate that iCDG-MOHGAT outperforms many state-of-the-art models in terms of AUPR and AUROC. In the final prediction results, 91% of the predicted new driver genes have at least one supporting evidence of being cancer genes. In the laboratory, this model can serve as an effective tool for identifying cancer driver genes.

Conclusion: We have introduced a novel computational model named iCDG-MOHGAT, which precisely identifies cancer driver genes by integrating multi-omics pan-cancer data and intricate multidimensional gene networks, coupled with disease semantic similarity networks. Experimental results demonstrate that iCDG-MOHGAT outperforms many state-of-the-art models in terms of AUPR and AUROC. In the final prediction results, 91% of the predicted genes have supporting evidence. In the laboratory, this model can serve as an effective tool for identifying cancer driver genes.

Aims: Drug-target affinity (DTA) prediction is crucial for drug discovery and repositioning. However, existing deep learning-based methods often overlook the synergy between the topological structure of DTA networks and the multimodal features of drugs and targets themselves.

Methods: This study proposes a new method, MIGDTA, a DTA prediction method based on multi-source information and graph convolutional network (GCN), which enhances prediction accuracy by integrating local features with global interaction information. MIGDTA first constructs a drug molecular graph, a target protein graph, and a DTA network, while computing molecular fingerprints and protein descriptors. Subsequently, it employs a graph isomorphism network to learn graph features, a GCN to capture network features, and a multilayer prceptron to encode biological features. Then, it refines heterogeneous network and graph features iteratively through the GCN, and finally concatenates the fused features with biological features for affinity prediction.

Results: Comparative experiments on benchmark datasets demonstrate that MIGDTA significantly outperforms existing methods. On the Davis dataset, compared to the best baseline method, MIGDTA reduces mean squared error (MSE) to 0.185, increases CI by 0.006, and improves $r_m^2$ by 5%. Similar enhancements were observed on the KIBA dataset, where MIGDTA achieves an MSE of 0.130, along with 0.002 and 1% gains in CI and $r_m^2$, respectively.

Conclusion: Feature ablation studies verify the core role of graph features in modeling local structures and network features in capturing global topology, along with the supplementary importance of biological features. Comparative analyses of feature integration approaches confirm the effectiveness of the feature refinement module in fusing multimodal features and enhancing model discriminability.

Aims: The subcellular localization of viral proteins can give insight into virus replication, immune evasion, and the development of therapeutic targets. Traditional experimental methods for determining localization are time-consuming and costly to perform, which calls for robust computational approaches. In this paper, we propose designing a computational method for identifying the subcellular localization of viral proteins.

Methods: In the effort to improve feature extraction for viral protein subcellular localization, a novel hybrid deep learning architecture, SpanAttNet, was proposed by incorporating span-based convolution with spatial pyramid dilated convolution and a residual self-attention mechanism. Three commonly used sequence descriptors, AAC, PseAAC, and DDE, each combined with PCA for feature dimension reduction, were systematically used to benchmark SpanAttNet.

Results: Among the individual descriptors, the best performance was yielded by PseAAC (accuracy 93.95%, MCC 91.18% at ρ = 0.8 PCA reduction), while optimal performance from DDE was at minimum reduction (accuracy 87.00% at ρ = 0.2). Moreover, ensemble feature fusion across the various descriptors elevated SpanAttNet to its top performance, reaching an MCC of 93.79% and an F1-score of 92.91%, hence achieving the best balance between sensitivity and specificity. Compared to state-of-the-art models, SpanAttNet managed to consistently match or surpass predictive accuracy, demonstrating strong generalizability.

Conclusion: We establish SpanAttNet as a robust and biologically informed predictor for viral protein subcellular localization, with strong potential for extension to multi-label classification and broader proteomic applications.

Drug-Drug Interaction (DDI) prediction plays a critical role in ensuring clinical medication safety and optimizing therapeutic regimens, while also representing a significant challenge in the drug development process. With the rapid advancement of artificial intelligence technologies, computational methods based on machine learning and deep learning have emerged as the mainstream paradigm in DDI research. In this survey, we systematically review the latest research progress and establish a clear methodological taxonomy that traces the evolution from classical feature engineering to modern deep learning architectures. Beyond detailing foundational molecular representations, we provide a comprehensive overview of DDI prediction techniques, encompassing sequence-based models, graph-based models, Transformers, and Graph Transformers. Our analysis culminates in a dedicated discussion of emerging advanced strategy paradigms, such as multimodal fusion and specialized pre-training and fine-tuning schemes. Furthermore, we synthesize current challenges with contemporary solutions and discuss their practical implications for clinical decision support, providing a forward-looking perspective for the continued development of DDI prediction models.

Aims: Development of robust and effective methods for uncovering herb interactions and constructing herb–disease associations requires the integration of diverse biological and medical information. A key challenge in Traditional Chinese Medicine (TCM) research is to robustly uncover herb interactions and construct reliable herb–disease associations. This task requires handling the inherently high-dimensional, multi-label, and cross-domain nature of prescription data. Existing approaches provide limited representation capacity and insufficient integration of biomedical knowledge, restricting their ability to capture the complex semantics underlying the relationships between herbs and diseases.

Methods: To address the limitations of existing approaches, we propose MediHerb, a multi-modal enhanced framework for disease inference via herbal knowledge. MediHerb unifies five complementary modalities: molecular sequences, fingerprints, physicochemical properties, graphical prescription representations, and the description of TCM prescriptions into a shared latent space. An attention-based fusion mechanism aligns the semantics across molecular, herbal, and diagnostic levels, enabling multi-granularity reasoning. To further promote accessibility, a lightweight graphical interface has been developed to support interaction with both the model and open datasets.

Results: Experimental results on benchmark datasets demonstrate that MediHerb substantially outperforms existing baselines in herb–disease inference. Beyond predictive accuracy, the learned embeddings and model attention patterns reveal meaningful biological and pharmacological insights, confirming that MediHerb captures the mechanistic underpinnings of herb–disease associations.

Conclusion: MediHerb highlights the potential of knowledge-enhanced multi-modal fusion to bridge molecular, herbal, and clinical semantics, offering a more interpretable and holistic approach to understanding TCM prescriptions.

Neuropeptides are crucial signaling molecules that regulate diverse physiological processes spanning growth, social behavior, learning, memory, metabolism, homeostasis, reproduction, and neural differentiation across both nervous and peripheral systems. Dysregulation of neuropeptides signaling is closely linked to various pathological conditions, such as neurological disorders, metabolic diseases, cardiovascular conditions, and even cancer, positioning them as potential therapeutic agents or targets for intervention. In recent years, research into neuropeptides has accelerated, with vast amounts of data continuously accumulating in multiple databases. However, the study of neuropeptides is often impeded by the need for extensive and time-consuming experimental investigations. As a result, computational tools have become essential for the rapid, large-scale identification of neuropeptides. This review systematically discusses neuropeptide-related databases and computational tools. These databases organize extensive data on neuropeptide sequences, structures, and functions. Among these, NeuroPep2.0, with 11,417 neuropeptide entries, is currently the most widely used dataset for neuropeptide prediction. Additionally, this review explores the application of computational approaches in neuropeptide prediction. While early methods predominantly relied on homologous sequence alignment and biochemical feature statistics, recent advances in machine learning have significantly enhanced prediction accuracy and efficiency. Tools such as NeuroPred-PLM and DeepNeuropePred, developed by our research group using protein language models, have substantially improved prediction performance. In conclusion, this review provides a comprehensive overview of current neuropeptide databases and computational tools, offering researchers a thorough survey of available resources and analytical methods, and emphasizing the necessity of continuous optimization to advance neuropeptide research and its therapeutic applications.